To the Editor,
We read with great interest the letter of Landi et al.
1
in which the authors reported solid data about the persistence of virus particles
in SARS-CoV-2 patients after the acute phase of epidemic infection. In particular,
authors found that 20,6% of patients were tested positive again after at least one
month from post-acute care admission (on a total of 29 examined patients).
Results showed by Landi and colleagues
1
strongly suggest that a significant number of recovered SARS-CoV-2 patients still
could be potentially asymptomatic carriers of the virus. According to these data authors
also suggest the modification of the current Italy guidelines for the management of
SARS-CoV-2 patients
2
proposing two consecutive negative RT-PCR test results together with the clinical
evidence of symptoms improvement before discharge from the hospital and discontinuation
of quarantine.
In our opinion this study highlighted a great issue for the public health in terms
of both virus spread control and safety of healthcare professionals. Indeed, asymptomatic
carriers of the virus could transmit the infection during the frequently post-admission
visits to which they are often subjected.
Our recent investigation can extend the considerations reported by Landi et al.
1
shedding new light on the capability of SARS-CoV-2 particles to also persist in deceased
persons. In fact, we studied the persistence of SARS-CoV-2 by real time-PCR in 24
hours post-mortem swabs of subjects who died from SARS-CoV-2 infection. RT-PCR analysis
targeted the common envelope (E) gene, the specific nucleocapsid (N) and RNA-dependent-RNA-polymerase
(RdRp) genes complying with the international validated protocols
3
both at T0 and after 24 hours. The results of rRT-PCR test are showed as cycle-threshold
(Ct) values. Ct-values less than 35 were considered as positive tests. Experimental
procedures were performed according to the authorization of the independent ethics
committee of the “Policlinico Tor Vergata” for the study of the presence of SARS-CoV-2
in the organic tissues and fluids obtained from autoptic examinations (#77.20).
15 patients with SARS-CoV-2 interstitial pneumonia were included in this study, 8
males and 6 females (age range 46-92, mean 73,1 +/- 11,7). The duration of hospitalization
ranged from 1 to 108 days (mean 22,1 +/- 13,4). All patients had more than one associated
disease (8 had heart failure, arrhythmia or ischemic heart disease, 6 hypertension,
6 dementia, 3 chronic renal failure, 2 neoplasms, 2 diabetes, 2 obesity, 1 recent
kidney transplantation, 1 stroke).
RT-PCR investigations showed that SARS-CoV-2 viral RNA was still detectable in 60%
of cases 24 hours after death. Noteworthy, our data showed an increase of the viral
load in more of 50% of positive individuals 24 hours post-mortem (decrease of Ct value).
It is important to note that more of 20% of deceased were positive for all evaluated
genes (E, N and RdRp) also after 24 hours. This fact allows to consider the autoptic
exam of a SARS-CoV-2 positive deceased an highly dangerous procedure also after 24
hours.
From biological point of view, this unexpected finding can be explained by the increase
in chest pressure due to the formation of intestinal gas with consequent compression
on the diaphragm (Fig. 1
A) and / or by post-mortem cell lysis (fig. 1B). In this case, there would be an indirect
and greater release of the alveolar contents and virus-containing secretions in the
upper airways. In addition, it is possible to hypothesize the existence of a post-mortem
time window in which spike positive alive human cells can be infected by SARS-COV-2
and release great amount of viral particles, especially in absence of circulating
immune cells (Fig. 1C). Indeed, several studies on animal models demonstrated that
many cells remain alive and thriving after an organism's death. Amazingly, some of
these increase their activity in the first hours after death
4
. This interesting discovery has been dubbed the “Twilight of Death,” which refers
to the time frame between death and body's decomposition where not all of the body's
cells are yet dead. The authors suggest that the death phenomenon is more like a slow
shutdown process and not the simple off-switch many imagine it to be. Thus, pathological
process such as viral infections, could continue, or even increase, in the first hours
after death. However, we cannot exclude a false negative result on the first test.
According to literature, false negatives may be due mainly to inappropriate sample
taking or transport, or a low viral load, below the sensitivity limit of the technique.
5
To minimize the risk of sampling errors, in this study all nasopharyngeal swabs were
taken by a single well-trained operator using a previously described standard operating
procedure.
6
Therefore, we believe that further possible explanations cannot be excluded, especially
when considering the potential role of post-mortal transformative phenomena.
Figure 1
Hypothesis about the SARS-CoV-2 persistence in human body after death. A) The increase
in chest pressure due to the formation of intestinal gas with consequent compression
on the diaphragm can push out the SARS-CoV-2 particles from lower to upper airways.
B) The lysis of SARS-CoV-2 infected cells that occur after death can release a large
amount of viral particles in the upper airways. C) In the first hours after death
the SARS-CoV-2 can infect alive cells thus increasing the viral load. Created in Biorender.com.
Figure 1
The peculiar results emerged from our study can be considered of great scientific
interest and justify the need to adopt appropriate protective measures by both the
medico-legal team in the surveys on the investigative scenes and the staff of the
morgue.
7
,
8
Nonetheless, even in a hospital setting when a diagnostic autopsy is required, our
results highlight the importance of obtaining not only one post mortem swab, but at
least two, if not three, consecutive swabs before a patient can be considered SARS-CoV-2-negative
with a reasonable degree of certainty. This is particularly true for patients who
died during the transfer to the hospital or without medical intervention, for whom
autopsy is required with no exhaustive clinical data.
Declaration of Competing Interest
All authors have no conflict of interest.
Go to:
Abbreviations
Ct: cycle-threshold
E: envelope
N: nucleocapsid
RdRp: RNA-dependent-RNA-polymerase
RT-PCR: real-time- Polymerase Chain Reaction
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the Policlinico Tor vergata (Rome,
Italy) (#77.20).
Consent for publication
Not applicable.
Availability of data and material
All the data and material are available by emailing the corresponding author.
Consent for publication
The author gives consent for publication of this paper.
Funding
None
Authors' contributions
MS, SM and AM coordinated the overall study.
MS, SM, FS, OS, and AM were involved in the concept and the design of the study.
MS, SM, and AM drafted the manuscript.
FS, BC, MC, LA, MM, EG, MT, SB, and LTM contributed to the acquisition and the interpretation
of the data.
All the authors revised the manuscript and approved its final version.